- Home
- CIEN vs HALO Comparison
CIEN vs HALO Comparison
Compare CIEN & HALO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CIEN
- HALO
- Stock Information
- Founded
- CIEN 1992
- HALO 1998
- Country
- CIEN United States
- HALO United States
- Employees
- CIEN N/A
- HALO N/A
- Industry
- CIEN Telecommunications Equipment
- HALO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CIEN Utilities
- HALO Health Care
- Exchange
- CIEN Nasdaq
- HALO Nasdaq
- Market Cap
- CIEN 10.2B
- HALO 7.4B
- IPO Year
- CIEN 1997
- HALO N/A
- Fundamental
- Price
- CIEN $82.68
- HALO $56.60
- Analyst Decision
- CIEN Buy
- HALO Buy
- Analyst Count
- CIEN 14
- HALO 9
- Target Price
- CIEN $82.62
- HALO $63.56
- AVG Volume (30 Days)
- CIEN 2.2M
- HALO 2.9M
- Earning Date
- CIEN 09-03-2025
- HALO 08-05-2025
- Dividend Yield
- CIEN N/A
- HALO N/A
- EPS Growth
- CIEN N/A
- HALO 55.40
- EPS
- CIEN 0.73
- HALO 3.76
- Revenue
- CIEN $4,264,558,000.00
- HALO $1,084,306,000.00
- Revenue This Year
- CIEN $16.36
- HALO $25.77
- Revenue Next Year
- CIEN $10.15
- HALO $18.01
- P/E Ratio
- CIEN $113.02
- HALO $15.07
- Revenue Growth
- CIEN 2.86
- HALO 25.64
- 52 Week Low
- CIEN $44.89
- HALO $42.01
- 52 Week High
- CIEN $101.44
- HALO $70.51
- Technical
- Relative Strength Index (RSI)
- CIEN 61.60
- HALO 57.92
- Support Level
- CIEN $76.89
- HALO $51.06
- Resistance Level
- CIEN $81.84
- HALO $58.14
- Average True Range (ATR)
- CIEN 2.20
- HALO 1.35
- MACD
- CIEN 0.12
- HALO 0.57
- Stochastic Oscillator
- CIEN 90.61
- HALO 78.25
About CIEN Ciena Corporation
Ciena is a telecommunications equipment provider focused on optical transport technologies, with clients in a number of industries such as communication services providers, web-scale providers, cable operators, government, and large enterprises worldwide. The company provides equipment, software, and services that support transport, switching, aggregation, service delivery, and data traffic management.
About HALO Halozyme Therapeutics Inc.
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.